Constipation Treatment Market Report and Forecast 2024-2032

Constipation Treatment Market Report and Forecast 2024-2032


Constipation Treatment Market Report and Forecast 2024-2032

Constipation Treatment Market Outlook

The constipation treatment market size was valued at USD 9.1 billion in 2023, driven by development of new diagnostic biomarkers across the major markets. The market size is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, and likely to attain a value of USD 15.2 billion by 2032.

Constipation: Introduction

Constipation is a common digestive condition characterized by infrequent bowel movements or difficulty passing stools. It often results from a diet low in fiber, inadequate hydration, or lack of physical activity. Symptoms include hard, dry stools, straining during bowel movements, and a feeling of incomplete evacuation. Constipation can also be caused by certain medications or medical conditions. The treatment typically involves lifestyle changes like increased fiber intake, hydration, and exercise, sometimes supplemented by over-the-counter laxatives for temporary relief.

Key Trends in the Constipation Treatment Market

There's an increasing consumer preference towards natural and herbal remedies, driven by concerns over the side effects of conventional laxatives. This includes increased use of fiber supplements, probiotics, and herbal teas.

Pharmaceutical companies are investing in the development of new drugs that are more effective with fewer side effects. This includes medications that work by stimulating bowel movements or softening stool.

The market is seeing a surge in functional foods, like those high in fiber, and probiotics, which are known to aid digestion and alleviate constipation.

There's a growing trend of self-care, with more people seeking over-the-counter solutions for constipation. This is coupled with increased awareness about the importance of digestive health.

Emphasis on lifestyle modifications such as increased physical activity, proper hydration, and dietary changes is becoming more prevalent as a first-line approach to prevent and treat constipation.

Innovative technologies for the diagnosis and monitoring of gastrointestinal issues, including constipation, are on the rise, enhancing personalized treatment approaches.

With an aging global population, there's a growing focus on treating constipation in the elderly, who are more prone to the condition due to various factors like reduced mobility and medication side effects.

Increasing attention is being given to the pediatric segment, with the development of child-friendly, safe, and effective constipation treatments.

Constipation Treatment Market Segmentation

Constipation Treatment Market Segmentation

Market Breakup by Product Type

· Mu-Opioid Receptor Antagonists

· Laxative

· Chloride Channel-2 Activator

· Guanylate Cyclase-C (GC-C) Agonist

· Others

Market Breakup by Disease Type

· Opioid-Induced Constipation

· Chronic Idiopathic Constipation

· Irritable Bowel Syndrome with Constipation

Market Breakup by Prescription Type

· Corticosteroids Prescribed Drugs

· Over-the-Counter Drugs

Market Breakup by Distribution Channel

· Online Pharmacy

· Drug Store and Retail Pharmacy

· Other

Market Breakup by Region

· United States

· EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
· Japan

Constipation Treatment Market Overview

In North America, United States and Canada typically exhibit a high adoption rate of newer, prescription medications due to strong healthcare infrastructure and high patient awareness. There is a significant market for over the counter (OTC) laxatives and prescription drugs. Emphasis on lifestyle changes such as diet and exercise are prevalent. There's also a growing trend towards natural and organic remedies.

Similar to North America, there's a high adoption rate of new medications in Western Europe. The region also has strict regulatory standards for the approval of new drugs.

In Asia-Pacific, developed nations such as Japan, Australia, South Korea have advanced healthcare systems, like Western nations, and show openness to both modern and traditional treatments. In India, China, and Southeast Asia, the market is diverse, with a mix of modern healthcare facilities in urban areas and traditional remedies in rural regions.

Constipation Treatment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Takeda Pharmaceutical Company Ltd.
  • Ironwood Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Inc.
  • Abbott Laboratories
  • AstraZeneca Plc
  • Cosmo Pharmaceuticals NV
  • Sanofi S.A.
  • Bayer AG
  • Valeant Pharmaceuticals International Inc.
  • Pfizer Inc
  • Synergy Pharmaceuticals, Inc.
  • Janssen Pharmaceutical Company
  • Boehringer Ingelheim GmbH
  • Ardelyx Inc.
  • AbbVie Inc.
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Constipation Treatment Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Constipation Treatment Epidemiology Analysis – Seven Major Markets
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Constipation Treatment Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Constipation Treatment Epidemiology Forecast (2017-2032)
5.3.1 Germany Constipation Treatment Epidemiology Forecast (2017-2032)
5.3.2 France Constipation Treatment Epidemiology Forecast (2017-2032)
5.3.3 Italy Constipation Treatment Epidemiology Forecast (2017-2032)
5.3.4 Spain Constipation Treatment Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Constipation Treatment Epidemiology Forecast (2017-2032)
5.4 Japan Constipation Treatment Epidemiology Forecast (2017-2032)
6 Constipation Treatment Market Overview – 7MM
6.1 Constipation Treatment Market Historical Value (2017-2023)
6.2 Constipation Treatment Market Forecast Value (2024-2032)
7 Constipation Treatment Market Landscape – 7MM
7.1 Constipation Treatment Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Constipation Treatment Product Landscape
7.2.1 Analysis by Product Type
7.2.2 Analysis by Disease Type
8 Constipation Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Constipation Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Constipation Treatment Market Segmentation – 7MM
11.1 Constipation Treatment Market by Product Type
11.1.1 Market Overview
11.1.2 Mu-Opioid Receptor Antagonists
11.1.3 Laxative
11.1.4 Chloride Channel-2 Activator
11.1.5 Guanylate Cyclase-C (GC-C) Agonist
11.1.6 Others
11.2 Constipation Treatment Market by Disease Type
11.2.1 Market Overview
11.2.2 Opioid-Induced Constipation
11.2.3 Chronic Idiopathic Constipation
11.2.4 Irritable Bowel Syndrome with Constipation
11.3 Constipation Treatment Market by Prescription Type
11.3.1 Market Overview
11.3.2 Corticosteroids Prescribed Drugs
11.3.3 Over-the-Counter Drugs
11.4 Constipation Treatment Market by Distribution Channel
11.4.1 Market Overview
11.4.2 Online Pharmacy
11.4.3 Drug Store and Retail Pharmacy
11.4.4 Other
11.5 Constipation Treatment Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.5.4 Japan
12 United States Constipation Treatment Market
12.1 Constipation Treatment Market Historical Value (2017-2023)
12.2 Constipation Treatment Market Forecast Value (2024-2032)
12.2.1 Constipation Treatment Market by Product Type
12.2.2 Constipation Treatment Market by Disease Type
13 EU-4 and United Kingdom Constipation Treatment Market
13.1 Constipation Treatment Market Historical Value (2017-2023)
13.2 Constipation Treatment Market Forecast Value (2024-2032)
13.3 Germany Constipation Treatment Market Overview
13.3.1 Constipation Treatment Market by Product Type
13.3.2 Constipation Treatment Market by Disease Type
13.4 France Constipation Treatment Market Overview
13.4.1 Constipation Treatment Market by Product Type
13.4.2 Constipation Treatment Market by Disease Type
13.5 Italy Constipation Treatment Market Overview
13.5.1 Constipation Treatment Market by Product Type
13.5.2 Constipation Treatment Market by Disease Type
13.6 Spain Constipation Treatment Market Overview
13.6.1 Constipation Treatment Market by Product Type
13.6.2 Constipation Treatment Market by Disease Type
13.7 United Kingdom Constipation Treatment Market Overview
13.7.1 Constipation Treatment Market by Product Type
13.7.2 Constipation Treatment Market by Disease Type
14 Japan Constipation Treatment Market
14.1 Constipation Treatment Market Historical Value (2017-2023)
14.2 Constipation Treatment Market Forecast Value (2024-2032)
14.2.1 Constipation Treatment Market by Product Type
14.2.2 Constipation Treatment Market by Disease Type
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding and Investment Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnership and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 Takeda Pharmaceutical Company Ltd.
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisition
20.1.5 Certifications
20.2 Ironwood Pharmaceuticals, Inc.
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisition
20.2.5 Certifications
20.3 Salix Pharmaceuticals, Inc.
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisition
20.3.5 Certifications
20.4 Abbott Laboratories
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisition
20.4.5 Certifications
20.5 AstraZeneca Plc
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisition
20.5.5 Certifications
20.6 Cosmo Pharmaceuticals NV
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisition
20.6.5 Certifications
20.7 Sanofi S.A.
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisition
20.7.5 Certifications
20.8 Bayer AG
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisition
20.8.5 Certifications
20.9 Valeant Pharmaceuticals International Inc.
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisition
20.9.5 Certifications
20.10 Pfizer Inc
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisition
20.10.5 Certifications
20.11 Synergy Pharmaceuticals, Inc.
20.11.1 Financial Analysis
20.11.2 Product Portfolio
20.11.3 Demographic Reach and Achievements
20.11.4 Mergers and Acquisition
20.11.5 Certifications
20.12 Janssen Pharmaceutical Company
20.12.1 Financial Analysis
20.12.2 Product Portfolio
20.12.3 Demographic Reach and Achievements
20.12.4 Mergers and Acquisition
20.12.5 Certifications
20.13 Boehringer Ingelheim GmbH
20.13.1 Financial Analysis
20.13.2 Product Portfolio
20.13.3 Demographic Reach and Achievements
20.13.4 Mergers and Acquisition
20.13.5 Certifications
20.14 Ardelyx Inc.
20.14.1 Financial Analysis
20.14.2 Product Portfolio
20.14.3 Demographic Reach and Achievements
20.14.4 Mergers and Acquisition
20.14.5 Certifications
20.15 AbbVie Inc.
20.15.1 Financial Analysis
20.15.2 Product Portfolio
20.15.3 Demographic Reach and Achievements
20.15.4 Mergers and Acquisition
20.15.5 Certifications
21 Key Opinion Leaders (KOL) Insights (Additional Insight)
22 Company Competitiveness Analysis (Additional Insight)
22.1 Very Small Companies
22.2 Small Companies
22.3 Mid-Sized Companies
22.4 Large Companies
22.5 Very Large Companies
23 Payment Methods (Additional Insight)
23.1 Government Funded
23.2 Private Insurance
23.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings